| RS2518233282 |
ACO2
|
Health Risk |
Likely pathogenic |
ACO2-related disorder, ACO2-related disorder |
| RS2518236207 |
ACO2
|
Health Risk |
Likely pathogenic |
Optic atrophy 9, Optic atrophy 9 |
| RS2518236265 |
ACO2
|
Health Risk |
Likely pathogenic |
Optic atrophy 9, Optic atrophy 9 |
| RS2518236280 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518236588 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518236599 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518238622 |
TCF20
|
Health Risk |
Pathogenic |
— |
| RS2518238822 |
TCF20
|
Health Risk |
Likely pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518240864 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518241727 |
TCF20
|
Health Risk |
Pathogenic |
TCF20-related disorder, TCF20-related disorder |
| RS2518242171 |
TCF20
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2518242829 |
TCF20
|
Health Risk |
Likely pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518243341 |
TCF20
|
Health Risk |
Pathogenic |
— |
| RS2518244849 |
TCF20
|
Health Risk |
Pathogenic |
— |
| RS2518248717 |
TCF20
|
Health Risk |
Pathogenic |
— |
| RS2518249621 |
TCF20
|
Health Risk |
Pathogenic |
— |
| RS2518252276 |
HPS4
|
Health Risk |
Pathogenic |
— |
| RS2518262086 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518262220 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518262867 |
PCNT
|
Health Risk |
Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2518263394 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518263563 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518263805 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518263880 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518264355 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518285878 |
HPS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518287411 |
ADARB1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, microcephaly |
| RS2518295645 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518309690 |
PI4KA
|
Health Risk |
Pathogenic |
— |
| RS2518312698 |
MLC1
|
Health Risk |
Likely pathogenic |
— |
| RS2518313444 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518316990 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518317021 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518317033 |
MLC1
|
Health Risk |
Pathogenic |
— |
| RS2518317355 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518321342 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518321498 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518321662 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, ARSA-related disorder |
| RS2518322020 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518322092 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518322313 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518322373 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518322494 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518323495 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518324057 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518325834 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518326035 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518326252 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518326786 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518326922 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518326996 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518327103 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518327153 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518327296 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518327424 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518329356 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518329600 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518329660 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518329837 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518329977 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518330963 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518331282 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518331715 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518332037 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518332484 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518333393 |
MLC1
|
Health Risk |
Pathogenic |
— |
| RS2518333422 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518333469 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518333795 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518333804 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518333855 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518334049 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518334157 |
ARSL
|
Health Risk |
Pathogenic |
— |
| RS2518334179 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518334198 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518334330 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518334400 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518334579 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518336818 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518336823 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518336953 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS2518338237 |
MLC1
|
Health Risk |
Likely pathogenic |
— |
| RS2518346073 |
ARSL
|
Health Risk |
Likely pathogenic |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS2518346615 |
ARSL
|
Health Risk |
Pathogenic |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS2518357998 |
MLC1
|
Health Risk |
Pathogenic |
— |
| RS2518358218 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518359086 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518362817 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2518363378 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2518364241 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2518365137 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2518365694 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Lung cancer, Lung cancer |
| RS2518369116 |
ARSL
|
Health Risk |
Likely pathogenic |
X-linked chondrodysplasia punctata 1, X-linked chondrodysplasia punctata 1 |
| RS2518369951 |
MLC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518370183 |
MLC1
|
Health Risk |
Pathogenic |
— |
| RS2518370885 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2518371253 |
SHANK3
|
Health Risk |
Likely pathogenic |
SHANK3-related disorder, SHANK3-related disorder |
| RS2518371261 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS2518374358 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS2518385011 |
ARSL
|
Health Risk |
Pathogenic |
Chondrodysplasia punctata, brachytelephalangic |